Safa Mohanna

This person is no longer with EPFL

About this result

This page is automatically generated and may contain information that is not correct, complete, up-to-date, or relevant to your search query. The same applies to every other page on this website. Please make sure to verify the information with EPFL's official sources.

Related publications (3)

Please note that this is not a complete list of this person’s publications. It includes only semantically relevant works. For a full list, please refer to Infoscience.

About
Privacy
Disclaimer

Safa Mohanna

Nigrostriatal overabundance of alpha-synuclein leads to decreased vesicle density and deficits in dopamine release that correlate with reduced motor activity

Gene therapy for Parkinson's disease: viral gene delivery to revert a parkinsonian phenotype induced by alpha-synuclein over-expression

Perceptual learning, imagery and TMS

Nigrostriatal overabundance of alpha-synuclein leads to decreased vesicle density and deficits in dopamine release that correlate with reduced motor activity

Gene therapy for Parkinson's disease: viral gene delivery to revert a parkinsonian phenotype induced by alpha-synuclein over-expression

Perceptual learning, imagery and TMS